Security key
45719W205
Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value per share (IKT)
CUSIP: 45719W205
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 106,415,262
- Total 13F value
- $218,151,569
- Share change
- +35,184,865
- SEC-reported price per share
- $2.05
- Number of holders
- 73
- Value change
- +$72,128,708
- Number of buys
- 42
- Number of sells
- 15
- Shares outstanding
- 148,020,141
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
73
Top holders
10
IKT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Inhibikase Therapeutics, Inc. SEC filings
Inhibikase Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45719W205
Recent filing periods:
Ownership snapshot
Top reported holders of IKT - Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sands Capital Life Scienc...
Disclosed value leader
Sands Capital Life Scienc...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 11%
13D/G row: Sands Capital Life Sciences Pulse Fund II, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Sands Capital Life Sciences Pulse Fund II, L.P. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sands Capital Life Sciences Pulse Fund II, L.P.'s linked filing trail.
Comparable ownership
Top 5
Sands Capital Life Sciences Pulse...
11%
Fairmount Funds Management LLC
9.9%
Nantahala Capital Management, LLC
5.7%
ARMISTICE CAPITAL, LLC
5%
Sands Capital Alternatives, LLC
7.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sands Capital Life Sciences Pulse Fund II, L.P. |
13D/G
3/4/5
10%+ Owner
|
11%
|
$26,037,930
13,018,965 shares
|
+$4,137,930 | 31 Dec 2025 |
| Fairmount Funds Management LLC |
13D/G
13F
Company
|
9.9%
|
$24,922,202
12,461,101 shares
|
+$10,885,052 | 31 Dec 2025 |
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
5.7%
|
$14,075,832
7,037,916 shares
|
+$3,478,584 | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$7,975,554
3,529,006 shares
|
$0 | 31 Dec 2024 |
| Sands Capital Alternatives, LLC |
13F
Company
|
7.4%
|
$17,739,000
10,950,000 shares
|
— | 30 Sep 2025 |
| Soleus Capital Management, L.P. |
13F
Company
|
4.3%
|
$10,246,500
6,325,000 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
73
Shares
106,415,262
Rows available
73
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
53
Q4 2025 holders
73
Holder diff
20
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend